Baroda BNP Paribas Health And Wellness Fund · Direct · Growth
NAV
₹10.9769
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +8.50%
- 3Y
- —
- 5Y
- —
- Since Inception
- +8.91%
SIP returns (XIRR)
- 1Y
- +23.05%
- 3Y
- —
- 5Y
- —
- Since Inception
- +20.96%
Performance Comparison
Sectoral allocation
as of 30 Jun 2026- Pharmaceuticals & Biotechnology72.66%
- Healthcare Services17.24%
- Insurance5.44%
- IT - Services1.52%
- Retailing1.17%
Each sector links to the mutual funds most exposed to it.
Thinking about Baroda BNP Paribas Health And Wellness Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Baroda BNP Paribas Health and Wellness Fund Regular Growth
- 1Sun Pharmaceutical Industries Limited7.58%
- 2Lupin Limited6.56%
- 3Laurus Labs Limited6.31%
- 4Ipca Laboratories Limited5.80%
- 5Torrent Pharmaceuticals Limited5.43%
- 6Divi'S Laboratories Limited5.35%
- 7Apollo Hospitals Enterprise Limited4.87%
- 8Jb Chemicals & Pharmaceuticals Limited4.57%
- 9Fortis Healthcare Limited4.32%
- 10Astrazeneca Pharma India Limited3.87%
Investment Objective
Baroda BNP Paribas Health And Wellness Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Baroda BNP Paribas Health And Wellness Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Baroda BNP Paribas Mutual Fund. The fund has been operational for over 1 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations